March 19, 2013
Contact: Mike Barra (mbarra@ralandcorp.com)
Direct Phone: 585-598-1180 ext. 740
Third Trademark Issued
(BUFFALO, NY) Apr. 1, 2022—Efferent Labs, Inc., a preclinical-stage biodevice company focused on in
Efferent Labs presents the novel CytoComm™ Living Biosensor at Health Care Capital Forum
Related Posts
Efferent Labs Issued 6th Patent
(BUFFALO, NY) Feb. 15, 2022—Efferent Labs, Inc., a preclinical-stage biodevice company focused on in
Efferent Labs Expands Development Collaboration with Gore
(CHARLESTON, S.C.) Mar 6, 2021/GlobeNewswire/ – Today, Efferent Labs announces an expanded development
About Us
Efferent Labs offers a live, cellular data acquisition platform that will radically alter the landscape of pre-clinical research in animals.
Let’s Socialize
Popular Post
Third Trademark Issued
April 1, 2022
Efferent Labs Issued 6th Patent
February 15, 2022